Notas de Prensa Supira Medical Announces FDA Approval for SUPPORT II Pivotal Trial, Advances in Cardiogenic Shock, and Appointment of D. Keith Grossman to Board of DirectorsSupira Medical anuncia la aprobación de la FDA para el ensayo pivotal SUPPORT IISupira Medical anuncia la aprobación de la FDA para el ensayo pivotal SUPPORT II, los avances en el shock cardiogénico y el nombramiento de D. Keith Grossman como miembro de la junta directivaTreon Secures €6.8 Million Investment Led by ACME Capital to Accelerate Industrial AI InnovationMeet CAS Newton: Agentic AI built for scienceDuck Creek Launches Duck Creek Reinsurance with Active Delivery to Help Insurers Simplify Program Management and Improve Financial ControlUtorg Taps Wirex BaaS to Unlock Onchain Neobanking services for 300,000+ Hÿper App UsersH55 Delivers First Commercial, Certifiable Propulsion Battery Modules to BRM Aero for the Bristell B23 Energic ProgramUkrainian tea brand Tea Moments enters the UK market at Food & Drink Expo 2026Treon obtiene una inversión de 6,8 millones de euros liderada por ACME Capital«2026-04-052026-04-062026-04-072026-04-08«1234567»2026-04-09»